An Observational Prospective Study to Characterize Patients Initiating Enerzair® Breezhaler®, With or Without Sensor, as a Maintenance Treatment for Asthma

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

February 15, 2022

Primary Completion Date

May 15, 2023

Study Completion Date

May 15, 2023

Conditions
Asthma
Interventions
OTHER

IND/GLY/MF

Prospective observational cohort study. There is no treatment allocation. Patients will be invited to participate in the study when attending participating community pharmacies with a first prescription of IND/GLY/MF with sensor or IND/GLY/MF without sensor

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY